about
Trends and Determinants of Osteoporosis Treatment and Screening in Patients with Rheumatoid Arthritis Compared to Osteoarthritis.Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis.Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis.Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.Validation of the rheumatic disease comorbidity index.Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions.Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure.Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survivalWhat Is Most Important in Rheumatoid Arthritis Treatment - Where You Are, Who You Are, or Where You Are Going?Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid ArthritisCorrelation of the Multi-Biomarker Disease Activity Score with Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-AnalysisPost-traumatic stress disorder and serum cytokine and chemokine concentrations in patients with rheumatoid arthritisObesity, Weight Loss, and Progression of Disability in Rheumatoid ArthritisReplyComparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary FibrosisUltrasound Doppler and tenosynovial fluid analysis in tenosynovitis2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity MeasuresRisk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic DrugsHLA-DRB1 Haplotypes, Shared Epitope, and Disease Outcomes in US Veterans with Rheumatoid ArthritisChanges in Alcohol Use and Associations With Disease Activity, Health Status, and Mortality in Rheumatoid Arthritis"Methotrexate and NSAIDs in rheumatoid arthritis-Confirmation of a known NSAIDs adverse effect rather than a dangerous combination"
P50
Q38644029-A57E1CC1-F1AA-4EDD-A400-6139985FA915Q38828456-9D971C01-BD79-475E-8582-36C55859AE8CQ38984167-57FF39FD-F360-4901-8727-49A099382C1CQ39825022-9F6F269F-B1F9-430E-A06A-D613519BE5DCQ40065347-33468E11-656E-47B2-9B6D-7014460FB747Q40813488-FFCDB744-7CA3-40D0-B529-92748AE8928AQ45940053-F46B49B4-B59B-4EEA-A020-12EF6656937CQ46366513-188E3979-A1E1-4E09-9DAE-C0854E9746EEQ50134651-778DA489-BA28-460E-B554-07EF6DB9BF83Q52312175-1F132E29-6B7B-4B94-9D5B-1E1E893196A6Q52583114-AE8C4EC0-6507-4E6F-8196-7F8298A65F38Q57045253-AB36B31E-6E28-4258-A60D-391490EEE7A4Q57058382-83645D94-E0C5-4844-9D8D-30998DFB302EQ57058395-ED7D5BC1-7EED-4759-8BFA-2B9F069EEDC5Q57461358-EDBAAB77-7808-4E5F-81AC-45C1C09EFB95Q64115911-6BFF36FC-8721-4AD4-ADF7-6EFCEB732771Q64125008-BCAF08CA-004D-4B08-B491-C9A94A2A6286Q89840649-DF987D63-675F-4F17-BE72-1301D896127DQ90157916-9255C483-962E-4175-A947-7B28A9F2066CQ90659595-204679C6-8511-402B-AE39-277169EF1536Q91222319-9D0F369A-4081-46AA-9D52-83DD3B952FB2Q91503648-76F7DDDE-F072-49BF-95B3-DCF6C418CFC6Q92061163-24E6C747-7158-4D12-AF79-04EC83748978Q92495794-CF7B37A7-DD25-4003-869A-A0509D63C78AQ93026932-A3978662-D1EF-4918-A18A-818B5DB5FE5A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bryant R England
@ast
Bryant R England
@en
Bryant R England
@es
Bryant R England
@nl
type
label
Bryant R England
@ast
Bryant R England
@en
Bryant R England
@es
Bryant R England
@nl
prefLabel
Bryant R England
@ast
Bryant R England
@en
Bryant R England
@es
Bryant R England
@nl
P106
P1153
56656199200
P31
P496
0000-0002-9649-3588